These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 1884860

  • 21. Cemiplimab treatment of squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
    Vasilev P, Kalev D, Karamanliev M, Dimitrov D, Troyanova P, Yordanova I.
    J Dtsch Dermatol Ges; 2023 Mar; 21(3):295-297. PubMed ID: 36855845
    [No Abstract] [Full Text] [Related]

  • 22. Anchorless keratinocyte survival: an emerging pathogenic mechanism for squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
    Rodeck U, Fertala A, Uitto J.
    Exp Dermatol; 2007 Jun; 16(6):465-7. PubMed ID: 17518985
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Recessive dystrophic epidermolysis bullosa-associated squamous-cell carcinoma: an enigmatic entity with complex pathogenesis.
    Rodeck U, Uitto J.
    J Invest Dermatol; 2007 Oct; 127(10):2295-6. PubMed ID: 17853916
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas.
    Kivisaari AK, Kallajoki M, Mirtti T, McGrath JA, Bauer JW, Weber F, Königová R, Sawamura D, Sato-Matsumura KC, Shimizu H, Csikós M, Sinemus K, Beckert W, Kähäri VM.
    Br J Dermatol; 2008 Apr; 158(4):778-85. PubMed ID: 18284387
    [Abstract] [Full Text] [Related]

  • 29. Large metastasizing squamous cell carcinoma in epidermolysis bullosa dystrophica Hallopeau-Siemens.
    Süss A, Sticherling M, Volz A, Frank R, Rudolph KD, Simon JC.
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):539-41. PubMed ID: 17373986
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Epidermolysis bullosa dystrophica of Hallopeau-Siemens and squamous-cell carcinoma: a case report.
    Van Rengen A, Degreef H.
    Dermatology; 1996 Apr; 192(4):418-9. PubMed ID: 8864399
    [Abstract] [Full Text] [Related]

  • 32. Epidemiology and natural history of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa patients: 20 years' experience of a reference centre in Spain.
    Castelo B, Viñal D, Maseda R, Ostios L, Sánchez D, García-Salvatierra B, Escámez MJ, Martínez-Santamaría L, Del Río M, Mora-Rillo M, Vilches Y, Beato MJ, López Gutiérrez JC, Romero N, Santos C, Miranda J, de Lucas R.
    Clin Transl Oncol; 2019 Nov; 21(11):1573-1577. PubMed ID: 30864020
    [Abstract] [Full Text] [Related]

  • 33. Reduced expression of insulin-like growth factor-binding protein-3 (IGFBP-3) in Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa.
    Mallipeddi R, Wessagowit V, South AP, Robson AM, Orchard GE, Eady RA, McGrath JA.
    J Invest Dermatol; 2004 May; 122(5):1302-9. PubMed ID: 15140235
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomas.
    Illmer J, Zauner R, Piñón Hofbauer J, Wimmer M, Gruner S, Ablinger M, Bischof J, Dorfer S, Hainzl S, Tober V, Bergson S, Sarig O, Samuelov L, Guttmann-Gruber C, Shalom-Feuerstein R, Sprecher E, Koller U, Laimer M, Bauer JW, Wally V.
    Br J Dermatol; 2023 Dec 20; 190(1):80-93. PubMed ID: 37681509
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Generalized dystrophic epidermolysis bullosa and development of squamous cell carcinoma].
    Petersen RB, Bonde CT, Schmidt G.
    Ugeskr Laeger; 2010 Nov 22; 172(47):3267-8. PubMed ID: 21092724
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Cutaneous squamous cell carcinomas: a complication of severe forms of hereditary epidermolysis bullosa].
    Bourrat E.
    Soins; 2023 Nov 22; 68(880):36-38. PubMed ID: 37931996
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.